MediVaes
ActiveSummary
MediVaes has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €179,516 and a net result of €73,496. Equity is growing by about 60% per year across the filed financial years. Its solvency ranks better than 72% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
04-02
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2023 to 2025net €73,496 ▲36.3%
Operating result €93,308, net result €73,496, both a record.
31-12
Financial
Liquidity more than doubledcurrent ratio 4.88
Current ratio from 1.99 to 4.88; short-term debt falls from €71,952 to €41,740.
31-12
Financial
Equity above €150,000equity €179,516 ▲69.3%
A profit in every financial year since 2023 builds equity to €179,516.
11-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Equity above €100,000equity €106,021 ▲103%
A profit in every financial year since 2023 builds equity to €106,021.
13-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.